Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange

• Status: Completed
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the role of inhaled corticosteroids to suppress nitric oxide gas exchange in stable patients with moderate-to-severe COPD who are current non-smokers and not on oral corticosteroids.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Arthur F Gelb MD
• Treatments: Bronchodilator Agents; Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination; Nitric Oxide; Salmeterol Xinafoate; Xhance

Criteria

Inclusion Criteria:

• Clinical diagnosis of copd

• Current non-smoker

• Not on oral corticosteroids

• Must be able to use Advair discus or salmeterol discus

Exclusion Criteria:

• Pregnancy

• Current smoker

• On corticosteroids

• Clinically unstable